GrowthCap Names Ampersand Capital Partners a Top Growth Equity Firm of 2024
BOSTON, Feb. 13, 2025 /PRNewswire/ -- Ampersand Capital Partners ("Ampersand"), a leading private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, has been recognized by GrowthCap as a Top Growth Equity Firm of 2024.
"We are honored to be named a top growth equity firm, following our recent distinction as a Top Private Equity Firm of 2024 by GrowthCap. At Ampersand, we are deeply committed to partnering with visionary founders and CEOs to drive innovation and long-term growth in the life sciences and healthcare sectors. This recognition reaffirms our dedication to building high-performing companies and delivering meaningful impact for both our investors and the broader industry," said Herb Hooper, Managing Partner of Ampersand.
The selection process began with a consideration set of several hundred firms. Final round candidates were then reviewed methodically on the strength of their nomination submissions. GrowthCap evaluated each firm's unique capabilities, sector expertise, investment judgment, demonstrated value creation, senior partner composition, talent retention, firm evolution, and firm momentum, among other attributes. A fraction of final round candidates was ultimately selected as awardees. Undeniably, the trait that the best firms share is a culture of integrity and excellence led by founders and partners of sound character and exceptional discipline.
To see the full list of honorees and learn more about the selection criteria and methodology, please visit the GrowthCap website.
Disclaimer: This award was provided by GrowthCap on February 13, 2025. Ampersand submitted a nomination to be considered for the GrowthCap Top Growth Equity Firms 2024 list and, once selected by GrowthCap as an honoree, Ampersand paid a publishing and copyright fee to GrowthCap to promote this award. The data provided in this award publication is for informational purposes only and should not be construed as investment advice, endorsement, nor recommendation. GrowthCap believes the information in this publication to be accurate but does not verify its accuracy independently and does not warrant or guarantee that it is accurate or complete. GrowthCap has no obligation to provide any updates or changes to the information. No investment decisions should be made using this information.
About Ampersand Capital Partners
Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors. For additional information, visit www.ampersandcapital.com or follow us on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/growthcap-names-ampersand-capital-partners-a-top-growth-equity-firm-of-2024-302376253.html
SOURCE Ampersand Capital Partners